OraSure Technologies, Inc.

OSUR Healthcare Medical Instruments & Supplies

OraSure Technologies, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $115.0 million, down 38.1% from fiscal 2024. In the quarter to June 2026, revenue fell 1.93%, EPS grew 134.6%, free cash flow fell 1.40% and total debt fell 8.27%, each against the same quarter a year earlier. Insiders bought in the last twelve months.

3.61 0.20 −5.25%
Market cap
$262.8M
P/E
0.0×
Fwd P/E
−3.9×
Dividend yield
—
F-score
3/9
Altman Z
1.47
Beneish M
−2.73
Dividend safety
n/a
Dec '16 Dec '17 Dec '18 Dec '19 Dec '20 Dec '21 Dec '22 Dec '23 Dec '24 Dec '25
P/E ratio
25.11 36.40 34.35 29.74 0.00 0.00 0.00 11.50 0.00 0.00
Piotroski F-Score
9 5 6 2 3 1 4 8 5 3
Altman Z-Score
13.99 18.75 14.46 8.00 8.35 5.34 3.60 8.60 2.97 1.47
P/S ratio
3.81 6.82 3.93 3.20 4.16 2.68 0.90 1.50 1.45 1.55
P/FCF ratio
24.15 47.82 21.80 1,010.71 0.00 0.00 0.00 4.63 11.40 0.00
Altman Z″-Score (non-manufacturers)
11.52 10.91 12.80 10.84 10.21 7.26 7.24 13.27 9.22 6.76
Beneish M-Score
(2.48) (1.47) (2.77) (2.26) (2.65) (2.28) (1.59) (3.69) (2.76) (2.73)
P/Operating CF
(839.96) (516.59) 49.97 (478.97) 197.97 (48.93) (19.28) 14.68 2,465.20 (19.77)
P/B ratio
2.63 4.41 2.52 1.61 1.79 1.64 0.95 1.41 0.65 0.52
Price to Tangible BV
3.12 4.96 2.75 1.93 2.10 1.92 1.09 1.54 0.76 0.64
EV/Sales
2.87 5.89 3.07 2.20 2.95 2.03 0.61 0.78 0.01 (0.19)
EV/EBITDA
14.18 21.23 15.98 13.11 120.28 317.55 0.00 5.91 0.00 0.35
EV/Operating CF
14.96 34.92 14.25 34.71 87.20 (13.41) (5.02) 2.24 0.04 0.44
EV/FCF
18.17 41.28 17.02 694.46 (24.27) (5.68) (2.13) 2.42 0.04 0.40
Quick Ratio
8.12 6.16 6.84 5.91 5.34 2.91 2.63 8.36 8.71 5.57
Current Ratio
9.02 6.88 7.84 6.86 6.21 4.40 4.71 9.77 9.95 6.58
Net Debt/EBITDA
(4.66) (3.37) (4.49) (5.97) (49.53) (101.13) 16.11 (5.41) 15.40 3.22
Debt/Assets
0.00% 0.00% 0.00% 0.39% 0.20% 0.42% 0.11% 0.05% 0.02% 0.02%
Debt/Equity
0.00 0.00 0.00 0.00 0.00 0.01 0.00 0.00 0.00 0.00
Asset Turnover
0.65 0.66 0.59 0.47 0.43 0.51 0.86 0.87 0.39 0.26
Operating CF/Net income
1.25 0.91 1.92 0.59 (0.39) 1.54 2.76 2.64 (1.40) 0.71
Capex/Depreciation
(0.77) (0.71) (0.98) (1.27) (3.08) (4.13) (4.17) (0.49) (0.35) (0.41)
ROE
11.42% 13.94% 7.53% 5.64% (4.23%) (5.90%) (4.60%) 13.50% (4.64%) (18.30%)
ROA
9.93% 12.28% 6.67% 5.01% (3.71%) (5.02%) (3.79%) 11.58% (4.05%) (15.57%)
ROIC
19.52% 24.61% 14.01% 7.64% (1.70%) (2.77%) (5.45%) 14.54% (12.37%) (31.75%)
Return on Tangible Assets
12.39% 14.66% 9.46% 7.50% (5.07%) (7.55%) (5.43%) 13.68% (5.65%) (26.30%)
Average Days of Receivables
56.45 92.90 69.97 87.23 82.55 70.79 66.69 36.16 46.78 70.46
Research and Development Expense of Revenue
7.61% 8.00% 8.94% 12.70% 18.07% 14.62% 9.35% 8.32% 14.02% 36.97%
Selling, General and Administrative Expense of Revenue
45.25% 34.63% 37.93% 43.44% 44.91% 40.69% 30.31% 23.31% 41.54% 64.16%
Intangible Assets out of Total Assets
0.14 0.10 0.08 0.15 0.13 0.12 0.11 0.08 0.12 0.15
Share Based Compensation of Revenue
4.73% 4.17% 8.38% 2.62% 4.16% 3.34% 3.00% 2.65% 6.41% 8.82%
Graham Net Nets
0.27 0.16 0.26 0.37 0.33 0.35 0.71 0.55 0.98 1.12
Graham Number
5.13 7.22 5.96 5.50 0.00 0.00 0.00 9.75 0.00 0.00
Earnings Yield
3.98% 2.75% 2.91% 3.36% (2.22%) (3.68%) (5.43%) 8.70% (7.20%) (38.43%)
Free Cash Flow Yield
4.14% 2.09% 4.59% 0.10% (2.92%) (13.35%) (31.96%) 21.62% 8.77% (29.93%)
Revenue per Share
2.31 2.83 2.97 2.51 2.54 3.25 5.34 5.53 2.50 1.57
Operating CF per Share
0.44 0.48 0.64 0.16 0.09 (0.49) (0.65) 1.93 0.37 (0.67)
Capex per Share
(0.08) (0.07) (0.10) (0.15) (0.43) (0.67) (0.88) (0.14) (0.05) (0.06)
Free Cash Flow per Share
0.36 0.40 0.54 0.01 (0.34) (1.16) (1.53) 1.79 0.32 (0.72)
Cash per Share
2.17 2.64 2.56 2.53 3.10 2.13 1.53 3.96 3.60 2.71
Shareholders Equity per Share
3.34 4.37 4.64 4.98 5.90 5.29 5.03 5.87 5.51 4.64
Interest Debt per Share
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Book value per Share
3.34 4.37 4.64 4.98 5.90 5.29 5.03 5.87 5.51 4.64
Free Cash Flow
20.25 23.82 32.75 0.49 (23.12) (83.50) (110.99) 131.28 23.58 (53.22)
Working Capital
139.11 189.67 191.33 191.84 242.40 231.24 256.13 346.92 299.74 222.11
Capital Expenditures
(4.35) (4.34) (6.34) (9.31) (28.92) (48.12) (63.79) (10.30) (3.80) (4.20)
Net Current Asset Value
134.36 183.79 187.12 182.40 232.99 218.85 245.44 334.29 263.90 199.57
EV/EBIT
18.15 24.43 19.60 18.28 0.00 0.00 0.00 9.70 0.00 0.30
Capex to Sales
0.03 0.03 0.03 0.06 0.17 0.21 0.16 0.03 0.02 0.04
Price to Operating Income
24.12 28.31 25.11 26.61 0.00 0.00 0.00 18.58 0.00 0.00
Other line items
Depreciation/Fixed assets
0.28 0.28 0.27 0.24 0.18 0.16 0.26 0.46 0.24 0.26
Cash ROIC
6.60% 5.75% 7.44% 0.11% (3.80%) (15.59%) (23.33%) 18.20% 3.48% (9.85%)
Accounts Receivable Turnover
6.56 5.36 4.70 4.31 4.53 5.55 6.67 7.31 5.81 5.00
Accounts Payable Turnover
8.27 9.17 6.54 5.95 5.18 5.11 7.24 9.14 9.98 9.10
Inventory Turnover
3.21 4.37 3.23 2.61 2.54 2.73 3.21 3.26 2.60 2.05
Average Days of Payables
42.10 54.81 56.78 58.18 90.96 88.12 58.05 20.53 28.03 35.62
Days of Inventory on Hand
107.21 103.66 122.62 140.81 166.49 167.09 146.13 74.33 117.27 169.66
Average Receivables
19.55 31.17 38.68 35.90 37.89 42.08 58.06 55.48 31.99 23.01
Average Payables
4.86 7.43 10.41 10.08 13.49 22.72 33.02 25.59 10.66 7.35
Average Inventory
12.52 15.57 21.12 23.02 27.51 42.50 74.42 71.66 40.91 32.63
Average Assets
198.63 252.07 305.89 332.43 401.88 457.73 452.59 463.51 481.25 441.41
Average Common Equity
172.64 221.97 270.73 295.26 352.86 389.55 372.48 397.55 420.50 375.58

Fold the line items

Columns are period end dates